Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2007 October;142(5) > Giornale Italiano di Dermatologia e Venereologia 2007 October;142(5):613-5

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

THERAPEUTICAL NOTES  


Giornale Italiano di Dermatologia e Venereologia 2007 October;142(5):613-5

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

A randomized, parallel-group, open clinical study to assess the efficacy and safety of adapalene 0.1% gel once daily compared to twice daily in patients with mild moderate acne

Shemer A. 1, Trau H. 1, Davidovici B. 2, Amichai B. 2

1 Department of Dermatology Sheba Medical Center, Tel-Hashomer Tel-Aviv, Israel 2 Tel-Nordoy Clinic Clalit Health Services, Tel-Aviv, Israel


PDF  


Aim. To establish the efficacy and safety of adapalene 0.1% gel once daily versus twice daily in patients with mild to moderate acne, and to determinate if twice daily application will improve significantly the efficacy of the drug.
Methods. It was a randomized, comparative, parallel-group, open study involving 167 patients.
Results. The study demonstrated therapeutic similarity between adapalene gel applied once and twice daily. Side effects were similar and minimal, consisting mainly of mild irritant dermatitis.
Conclusion. No statistically difference between the efficacy and safety of adapalene gel once or twice daily has been demonstrated. A treatment regimen of one application per day may significantly enhance compliance in acne patients.

top of page

Publication History

Cite this article as

Corresponding author e-mail